The FDA approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3 glomerulopathy ...

A urine test strip method using the semi-quantitative albumin-to-creatinine ratio can enhance the early detection of chronic ...

In Virginia, health statistics show more than 20,000 people depend on dialysis and just a few thousand fewer have had kidney ...

Advanced treatments for kidney failure offers patients improved survival rates and quality of life. Discover the options from ...

Discover these kidney-friendly superfoods that can help manage symptoms, provide essential nutrients, and add delicious ...

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

The study, published in the Journal of Veterinary Internal Medicine, examined the effects of paricalcitol -- a synthetic form ...

According to the CDC, around 37 million American adults have chronic kidney disease, and millions more are at risk of developing it.

In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...

Sponsor: Kidneys for Communities Kidney disease is one of the leading causes of death in America, with nearly 100,000 people ...

Addressing patients with chronic kidney disease requires a commitment to data, education, and community, specifically in those affected by social determinants of health (SDOH).